Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison
- PMID: 33252169
- PMCID: PMC7873322
- DOI: 10.1002/onco.13619
Edmonton Symptom Assessment Scale Time Duration of Self-Completion Versus Assisted Completion in Patients with Advanced Cancer: A Randomized Comparison
Abstract
Introduction: To compare the time duration of self-completion (SC) of the Edmonton Symptom Assessment Scale (ESAS) by patients with advanced cancer (ACPs) versus assisted completion (AC) with a health care professional.
Materials and methods: In this randomized comparison of ACPs seen in initial consultation at the outpatient Supportive Care Center at MD Anderson, ACPs who have never completed the ESAS at MD Anderson were allocated (1:1) to either SC of the ESAS form versus AC by a nurse. Time of completion was measured by the nurse using a stopwatch. Patients completed the Rapid Estimate of Adult Literacy in Medicine (REALM) test prior to administration of the ESAS. In the SC group, the nurse reviewed the responses to verify that the reported ESAS scores were correct.
Results: A total of 126 ACPs were enrolled (69 patients to AC and 57 to SC). Seventy-one patients were female, median age was 60 years, and median REALM score was 65. Median (interquartile range) time (in seconds) of SC was significantly less than AC (73 [42.9-89.1] vs. 109 [79.5-136.7], p < .0001). With nurse review time included, median time of SC increased to 117 seconds, which was not significantly different from AC (p = .28). Lower literacy (REALM) score and shortness of breath were significantly associated with increased completion time (p = .007).
Conclusion: Regular use of ESAS will have minimal impact on clinical time, as it can be completed in about 1 minute and provides a concise yet comprehensive and multidimensional perspective of symptoms that affect quality of life of patients with cancer.
Implications for practice: Because the Edmonton Symptom Assessment Scale can be completed in less than 2 minutes, hopefully the routine use of this simple yet comprehensive and multidimensional symptom assessment tool will be used at all medical visits in all patients with cancer so that the timely management of symptoms affecting patients' lives and treatment courses can occur, further enhancing personalized cancer care.
Keywords: Symptom assessment • Palliative care • Supportive care.
© 2020 AlphaMed Press.
Conflict of interest statement
Similar articles
-
The impact of automated screening with Edmonton Symptom Assessment System (ESAS) on health-related quality of life, supportive care needs, and patient satisfaction with care in 268 ambulatory cancer patients.Support Care Cancer. 2019 Jan;27(1):209-218. doi: 10.1007/s00520-018-4304-0. Epub 2018 Jun 21. Support Care Cancer. 2019. PMID: 29931490
-
Edmonton symptom assessment scale: Italian validation in two palliative care settings.Support Care Cancer. 2006 Jan;14(1):30-7. doi: 10.1007/s00520-005-0834-3. Epub 2005 Jun 4. Support Care Cancer. 2006. PMID: 15937688
-
Development of a French Version of the Edmonton Symptom Assessment System-Revised: A Pilot Study of Palliative Care Patients' Perspectives.J Palliat Med. 2017 Sep;20(9):966-976. doi: 10.1089/jpm.2016.0510. Epub 2017 Apr 27. J Palliat Med. 2017. PMID: 28448236
-
Prediction of breast cancer-related outcomes with the Edmonton Symptom Assessment Scale: A literature review.Support Care Cancer. 2021 Feb;29(2):595-603. doi: 10.1007/s00520-020-05755-9. Epub 2020 Sep 11. Support Care Cancer. 2021. PMID: 32918128 Review.
-
The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.J Pain Symptom Manage. 2017 Mar;53(3):630-643. doi: 10.1016/j.jpainsymman.2016.10.370. Epub 2016 Dec 29. J Pain Symptom Manage. 2017. PMID: 28042071 Free PMC article. Review.
Cited by
-
Intensity of Symptoms and Perception of Quality of Life on Admission to Palliative Care: Reality of a Portuguese Team.Healthcare (Basel). 2024 Aug 1;12(15):1529. doi: 10.3390/healthcare12151529. Healthcare (Basel). 2024. PMID: 39120232 Free PMC article.
-
Exploring the Influence of the Edmonton Symptom Assessment System Implementation in Palliative Care Patients: A Systematic Review.Cureus. 2024 Oct 6;16(10):e70914. doi: 10.7759/cureus.70914. eCollection 2024 Oct. Cureus. 2024. PMID: 39502990 Free PMC article. Review.
-
Implementing routine collection of EQ-5D-5L in a breast cancer outpatient clinic.PLoS One. 2024 Aug 27;19(8):e0307225. doi: 10.1371/journal.pone.0307225. eCollection 2024. PLoS One. 2024. PMID: 39190702 Free PMC article.
-
The Edmonton Symptom Assessment System is a valid, reliable, and responsive tool to assess symptom burden in decompensated cirrhosis.Hepatol Commun. 2024 Mar 18;8(4):e0385. doi: 10.1097/HC9.0000000000000385. eCollection 2024 Apr 1. Hepatol Commun. 2024. PMID: 38497942 Free PMC article.
-
Association of Edmonton Symptom Assessment System Global Distress Score With Overall Survival in Patients With Advanced Cancer.JAMA Netw Open. 2021 Jul 1;4(7):e2117295. doi: 10.1001/jamanetworkopen.2021.17295. JAMA Netw Open. 2021. PMID: 34269810 Free PMC article.
References
-
- Bruera E, Kuehn N, Miller MJ et al. The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 1991;7:6–9. - PubMed
-
- Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000;88:2164–2171. - PubMed
-
- Nekolaichuk C, Watanabe S, Beaumont C. The Edmonton Symptom Assessment System: A 15‐year retrospective review of validation studies (1991‐2006). Palliat Med 2008;22:111–122. - PubMed
-
- Philip J, Smith WB, Craft P et al. Concurrent validity of the modified Edmonton Symptom Assessment System with the rotterdam symptom checklist and the brief pain inventory. Support Care Cancer 1998;6:539–541. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical